Every lot has its own COA — HPLC purity + MS identityMinimum 1 kit (10 vials) per SKUQuotes in USD · other currencies on request
Illustrative packaging. Supplied materials and packaging vary by order.

Hormone & growth axis · Research peptides

AOD9604

AOD9604 is listed as a research peptides material for qualified research and analytical procurement workflows.

  • Every lot ships with its COA — HPLC purity + MS identity
  • Purity specification ≥ 99.0%
  • From 1 kit (10 vials) per SKU
  • Written quote by email or WhatsApp

This entry is on the controlled SKU list; the first reply confirms its technical scope before procurement.

Specification

$101.20 / kit of 10 vials

$10.12 per vial · line total $101.20

kit · 10 vials

Need another spec, a larger fill or custom labelling?

Reference prices · AOD9604 5 mg
Kits on your quote listPrice / kit
Retail · 1–4 kits$101.20
Wholesale · 5–19 kits (−20%)$80.96
20+ kitsAsk for a quote

Kits count across your whole quote list, so different products add up. Pricing FAQ

Reference prices in USD, per kit of 10 vials. The final price is the one on your written quote. Need another currency? Your sales representative can quote it.

Specifications

AOD9604 parameters

CAS number221231-10-3
Molecular formulaC78H123N23O23S2
Molecular weight1815.1 g/mol
PubChem CID71300630
Purity specification≥ 99.0% (HPLC)
AppearanceWhite to off-white lyophilized powder
Specifications2 mg, 5 mg, 6 mg, 10 mg
Kit10 vials per kit · minimum 1 kit per SKU
StorageStorage and handling requirements are configuration- and lot-specific; request the applicable documentation before ordering.
Specifications and reference prices
SKUContentPrice / kitPer vial
AOD22 mgOn request—
AOD55 mg$101.20$10.12
AOD66 mgOn request—
AOD1010 mg$195.50$19.55

Another format

AOD9604 in a nasal spray bottle

Strengths
2 mg · 5 mg · 10 mg
Fill
10 mL or 20 mL
At least
10 bottles of one strength and size
Dispatched from
US stock, to US addresses

Nasal sprays are quoted by our sales team, separately from the kits on your quote list.

Black 10 mL nasal spray bottle with a clear dust cap
Spray bottle, 10 mL

Test results for every lot

Each lot of AOD9604 has its own certificate of analysis with HPLC purity and mass-spectrometry (MS) identity. Other tests — water content, counter-ion, endotoxin — are available on request and listed on the COA when tested.

Batch COAs 4

AOD9604 2 mg batch coa: first page, low-resolution preview

Batch COA, lot release

AOD9604

2 mg

HPLC purity · MS identity

AOD9604 5 mg batch coa: first page, low-resolution preview

Batch COA, lot release

AOD9604

5 mg

HPLC purity · MS identity

AOD9604 6 mg batch coa: first page, low-resolution preview

Batch COA, lot release

AOD9604

6 mg

HPLC purity · MS identity

AOD9604 10 mg batch coa: first page, low-resolution preview

Batch COA, lot release

AOD9604

10 mg

HPLC purity · MS identity

Previews show the first page only, at a resolution where small print cannot be read; numbers, dates, names and signatures are covered. The full, clear copy comes from our sales team.

COA of the batch you receive: ask our sales team.

Independent test fails? Full refund. How the refund works

How to read a COA →

Research background

About AOD9604

AOD9604 is a modified analog of the C-terminal 176-191 fragment of human growth hormone, developed at Monash University in Australia as a lipolytic / anti-obesity research and clinical-development candidate. The molecule consists of the native HGH(176-191) sequence with an additional N-terminal tyrosine residue added to support iodination for tracking studies during preclinical development. AOD9604 retains the lipolytic activity associated with the HGH C-terminal region (the segment hypothesized to drive fat-cell lipolysis through a non-GH-receptor mechanism) while lacking the broader anabolic effects mediated by the full-length HGH molecule's central regions. The molecule advanced through Phase 2 clinical development for obesity but did not achieve regulatory approval; it has since transitioned to research-use and dietary-supplement markets in some jurisdictions.

Medabol supplies lyophilized AOD9604 to a ≥99.0% HPLC purity specification with batch-specific COA. The N-terminal tyrosine makes AOD9604 a different molecule from the unmodified HGH Fragment 176-191; what Medabol supplies is AOD9604. Four standard fill sizes (2, 5, 6 and 10 mg) cover typical research and compounding workflows.

Selected literature

  1. Ng FM, Sun J, Sharma L, Libinaka R, Jiang WJ, Gianello R. Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone. Horm Res. 2000;53(6):274-278.
  2. Heffernan M, Summers RJ, Thorburn A, Ogru E, Gianello R, Jiang WJ, Ng FM. The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta3-AR knock-out mice. Endocrinology. 2001;142(12):5182-5189.
  3. Kwon DR, Park GY. Effect of intra-articular injection of AOD9604 with or without hyaluronic acid in rabbit osteoarthritis model. Ann Clin Lab Sci. 2015;45(4):426-432.
  4. Moré MI, Kenley D. Safety and metabolism of AOD9604, a novel nutraceutical ingredient for improved metabolic health. J Endocrinol Metab. 2014;4(3):64-77.
  5. Stier H, Vos E, Kenley D. Safety and tolerability of the hexadecapeptide AOD9604 in humans. J Endocrinol Metab. 2013;3(1-2):7-15.

For laboratory research use. This page describes published research and the material we supply; it is not medical advice.

AOD9604 FAQ

Why is AOD9604 considered an 'anti-obesity drug candidate' rather than just a research peptide?

AOD9604 was developed at Monash University in Australia and advanced through Phase 2b clinical trials for obesity as a registered drug-development program. The trials produced modest weight-loss signals (smaller than what GLP-1 agonists have since demonstrated), and the program did not achieve regulatory approval as a finished drug. Following discontinuation of the obesity-drug program, AOD9604 transitioned to research-use and to dietary-supplement markets in some jurisdictions, where it is marketed under various brand names. The 'anti-obesity drug candidate' framing reflects the molecule's clinical-development history; buyers should not assume the molecule is an approved drug.

Is AOD9604 a GH analog, and does it activate the GH receptor?

AOD9604 is derived from the C-terminal region of human GH (residues 176-191) but is not a GH receptor agonist, the GH-receptor-binding region of full-length GH is in the central portion of the protein, not the C-terminal fragment. AOD9604's lipolytic activity is hypothesized to act through a separate, non-GH-receptor mechanism. This is the key pharmacological distinction from full-length recombinant HGH: AOD9604 retains the lipolytic effects associated with the C-terminal region of GH but lacks the broader anabolic and IGF-1-stimulating effects mediated by the central GH-receptor-binding region. The downstream consequence is a substantially narrower pharmacological profile than HGH.

How to order

Ordering AOD9604 from Medabol

Kit and minimum
AOD9604 is sold by the kit: 10 vials of one specification (2 mg, 5 mg, 6 mg and 10 mg). The minimum is 1 kit per SKU, so an individual buyer can order a single kit and a lab can order many.
Price
Reference prices are listed per kit above, from $101.20. The kits of your whole quote list count together — 5–19 kits are 20% off every kit, and from 20 kits our sales team quotes the price — so AOD9604 adds up with anything else you order; your written quote has the final price.
Documents
Every lot has its own COA with HPLC purity and MS identity; the order ships with the certificate of its lot, and our sales team sends it before you order if you ask.
Shipping
Orders ship from China by international express courier. Shipping from $80 per order; the written quote confirms the exact charge for your destination.
Payment
Nothing is paid on this website. After you send your quote list, a sales representative confirms the amount and shipping on WhatsApp or by email and tells you in that chat how to pay.
Research goal
Listed under Hormone & growth axis — GH secretagogues, GHRH analogues, IGF-1 variants and reproductive-axis peptides.

Questions first?

Ask about AOD9604.

Quantities, documents, timing or a spec that is not listed — the reply comes from a sales representative.

Required for Chat on WhatsApp.